Cigna's Evernorth business caps GLP-1 drug copays at $200 or less, aiming to boost affordability for patients and cut costs for health plan sponsors. The Cigna Group (NYSE:CI)’s Evernorth ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

A bipartisan bill soon to be introduced in the state Legislature seeks to decrease the cost of GLP-1 drugs in Pennsylvania.

Omada Health closed 21% higher in its Nasdaq debut after raising $150 million. Backed by strong growth and GLP-1 momentum, ...

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated ...

People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, including Alzheimer's, but an increase in some other conditions like kidney ...

As earlier outlined, short-term studies in animals and humans have shown GLP-1 to have some direct vasorelaxation action, cardioprotective effects in models of ischemia-reperfusion injury ...

There, Williamson was prescribed her first GLP-1 injectable, Saxenda. Six-and-a-half years later, Williamson has shed 80 pounds and moves more easily despite struggling with arthritis.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland ...

GLP-1 medications are changing how millions experience food and beverages. Join us to discover the exclusive insights and science behind medication-altered taste perception and the massive market ...

DiveWire guarantees visibility for your news announcements through instant distribution to Healthcare Dive’s audience and its 141,500 newsletter subscribers for 21 days.